相关实验视频
Updated: Jun 21, 2025
05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
545
在老年人群中治疗慢性病
Seiji Kishi1, Hiroyuki Kadoya2, Naoki Kashihara3,4
1Department of Nephrology and Hypertension, Kawasaki Medical School, Kurashiki, Japan.
Nature reviews. Nephrology
|July 8, 2024
概括
在老年人群中,慢性病 (CKD) 的管理需要综合战略. 新兴疗法和以患者为中心的方法是改善CKD老年人治疗结果和生活质量的关键.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 老年病的医生 老年病的医生
- 公共卫生 公共卫生
背景情况:
- 全球人口老龄化正在增加老年人慢性病 (CKD) 的患病率.
- 老年人中CKD的管理面临着重大的医疗保健资源挑战.
- 标准CKD治疗目标包括减少心血管事件和衰竭进展.
研究的目的:
- 概述老龄人口中CKD的有效管理策略.
- 突出新兴药物治疗和非药物干预的作用.
- 强调以患者为中心的置疗法决策.
主要方法:
- 审查现行治疗指南和老年人慢性病的新兴疗法.
- 讨论非药物干预措施,如营养和运动.
- 探索影响置换治疗决策的因素.
- 在CKD管理中考虑数字健康整合.
主要成果:
- SGLT-2 抑制剂和GLP-1 受体激动剂在老年人中显示出对CKD管理的前景.
- 营养和运动疗法补充药物治疗,改善生活质量和认知功能.
- 个性化,以患者为中心的方法对于置换治疗决策至关重要.
- 数字技术为改变老年人群中CKD护理提供了潜力.
结论:
- 结合药物治疗,非药物干预和以患者为中心的护理的综合管理策略对于患有CKD的老年人来说至关重要.
- 新兴疗法和数字健康整合具有显著的潜力,可以改善老龄化人口中的CKD结果.
- 量身定制的治疗计划,考虑到年龄和认知之外的个人因素,对于治疗功能衰竭至关重要.
相关概念视频
01:11Renal Failure: Dose Adjustments
79
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
79
01:27Dialysis
288
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
288
01:17Factors Affecting Renal Clearance: Renal Impairment
74
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
74
01:22Heart Failure Drugs: Diuretics
362
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
362
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
419
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
419
01:22Alzheimer's Disease: Treatment
177
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
177